Trial Profile

Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events in Europe - a MultInatioNal ObservatIonal Study (SANTORINI)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 02 Sep 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Bempedoic acid/ezetimibe (Primary)
Indications Cardiovascular disorders; Hypercholesterolaemia
Focus Therapeutic Use
Acronyms SANTORINI
Sponsors Daiichi Sankyo Europe

Most Recent Events

31 Aug 2024 Results published in the Daiichi Sankyo Europe Media Release
31 Aug 2024 According to Daiichi Sankyo Europe Media Release, data from this trial presented at the European Society of Cardiology (ESC) Congress 2024.
23 May 2023 Results presented in the Daiichi Sankyo Europe Media Release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com